BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7791908)

  • 1. [Application of leukocyte-poor blood products. Work Group Blood Group Serology from the Medical Advisory Commission of the College for Blood Transfusion].
    van Rhenen DJ; Brand A
    Ned Tijdschr Geneeskd; 1995 Jun; 139(22):1124-6. PubMed ID: 7791908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological effects of erythrocyte and leukocyte transfusion. Work Group Blood Group Serology of the Medical Advisory Commission of the College for Blood Transfusion of the Netherlands Red Cross].
    Brand A; van Rhenen DJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(3):136-40. PubMed ID: 9053759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The application of leukocyte-poor blood products].
    Soeterboek AM; Welle FH; Marcelis JH; van der Loop CM
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1620-1. PubMed ID: 8768821
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse effects of transfusions caused by leukocytes.
    Raife TJ
    J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte filtration does not affect lymphocyte subpopulations and NK cell function in recipients of blood transfusions.
    Mathiesen O; Lund L; Brodthagen U; Gandrup P; Grunnet N; Balslev I; Jersild C
    Vox Sang; 1998; 74(1):15-20. PubMed ID: 9481855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
    Davies JK; Koh MB; Lowdell MW
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leucocyte removal and its clinical application].
    Zhao SM; Lin WC; Liu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):478-82. PubMed ID: 12513754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte depletion of cellular blood components.
    Lane TA
    Curr Opin Hematol; 1994 Nov; 1(6):443-51. PubMed ID: 9371321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukocyte depletion of blood products. Indications and technical implementation].
    Böck M; Heim MU
    Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation: the role of immunohematologic services.
    Myers JA
    Clin Lab Sci; 1990; 3(5):316-9. PubMed ID: 10150040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the blood-borne viruses: blood banking and transfusion medicine.
    Sherwood WC
    Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY; Guo KY; Song CY; Yang ; Li D
    Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple human cord blood transfusion for inducing low immune response].
    Zhao L; Wang C; Wang L; Li H; Yang Y; Lu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):395-7. PubMed ID: 12910671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion medicine 1994.
    Pineda A; Korbling M; Rock GA
    Rev Invest Clin; 1994 Apr; Suppl():101-15. PubMed ID: 7886293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.